ロード中...
Bortezomib in late antibody-mediated kidney transplant rejection (BORTEJECT Study): study protocol for a randomized controlled trial
BACKGROUND: Despite major advances in transplant medicine, improvements in long-term kidney allograft survival have not been commensurate with those observed shortly after transplantation. The formation of donor-specific antibodies (DSA) and ongoing antibody-mediated rejection (AMR) processes may cr...
保存先:
| 主要な著者: | , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4014747/ https://ncbi.nlm.nih.gov/pubmed/24708575 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1745-6215-15-107 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|